341 related articles for article (PubMed ID: 20713706)
1. Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies.
Ettenberg SA; Charlat O; Daley MP; Liu S; Vincent KJ; Stuart DD; Schuller AG; Yuan J; Ospina B; Green J; Yu Q; Walsh R; Li S; Schmitz R; Heine H; Bilic S; Ostrom L; Mosher R; Hartlepp KF; Zhu Z; Fawell S; Yao YM; Stover D; Finan PM; Porter JA; Sellers WR; Klagge IM; Cong F
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15473-8. PubMed ID: 20713706
[TBL] [Abstract][Full Text] [Related]
2. Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies.
Gong Y; Bourhis E; Chiu C; Stawicki S; DeAlmeida VI; Liu BY; Phamluong K; Cao TC; Carano RA; Ernst JA; Solloway M; Rubinfeld B; Hannoush RN; Wu Y; Polakis P; Costa M
PLoS One; 2010 Sep; 5(9):e12682. PubMed ID: 20856934
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6.
Bourhis E; Tam C; Franke Y; Bazan JF; Ernst J; Hwang J; Costa M; Cochran AG; Hannoush RN
J Biol Chem; 2010 Mar; 285(12):9172-9. PubMed ID: 20093360
[TBL] [Abstract][Full Text] [Related]
4. Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.
Lu W; Liu CC; Thottassery JV; Bu G; Li Y
Biochemistry; 2010 Jun; 49(22):4635-43. PubMed ID: 20446724
[TBL] [Abstract][Full Text] [Related]
5. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
Zhang J; Li Y; Liu Q; Lu W; Bu G
Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
[TBL] [Abstract][Full Text] [Related]
6. The first propeller domain of LRP6 regulates sensitivity to DKK1.
Binnerts ME; Tomasevic N; Bright JM; Leung J; Ahn VE; Kim KA; Zhan X; Liu S; Yonkovich S; Williams J; Zhou M; Gros D; Dixon M; Korver W; Weis WI; Abo A
Mol Biol Cell; 2009 Aug; 20(15):3552-60. PubMed ID: 19477926
[TBL] [Abstract][Full Text] [Related]
7. The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo.
Bryja V; Andersson ER; Schambony A; Esner M; Bryjová L; Biris KK; Hall AC; Kraft B; Cajanek L; Yamaguchi TP; Buckingham M; Arenas E
Mol Biol Cell; 2009 Feb; 20(3):924-36. PubMed ID: 19056682
[TBL] [Abstract][Full Text] [Related]
8. Both LRP5 and LRP6 receptors are required to respond to physiological Wnt ligands in mammary epithelial cells and fibroblasts.
Goel S; Chin EN; Fakhraldeen SA; Berry SM; Beebe DJ; Alexander CM
J Biol Chem; 2012 May; 287(20):16454-66. PubMed ID: 22433869
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of LRP6 function by casein kinase I epsilon phosphorylation.
Swiatek W; Kang H; Garcia BA; Shabanowitz J; Coombs GS; Hunt DF; Virshup DM
J Biol Chem; 2006 May; 281(18):12233-41. PubMed ID: 16513652
[TBL] [Abstract][Full Text] [Related]
10. Synthetic Multivalent Disulfide-Constrained Peptide Agonists Potentiate Wnt1/β-Catenin Signaling via LRP6 Coreceptor Clustering.
Thakur AK; Miller SE; Liau NPD; Hwang S; Hansen S; de Sousa E Melo F; Sudhamsu J; Hannoush RN
ACS Chem Biol; 2023 Apr; 18(4):772-784. PubMed ID: 36893429
[TBL] [Abstract][Full Text] [Related]
11. Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of beta-catenin signaling.
Yamamoto H; Sakane H; Yamamoto H; Michiue T; Kikuchi A
Dev Cell; 2008 Jul; 15(1):37-48. PubMed ID: 18606139
[TBL] [Abstract][Full Text] [Related]
12. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity.
Ellies DL; Viviano B; McCarthy J; Rey JP; Itasaki N; Saunders S; Krumlauf R
J Bone Miner Res; 2006 Nov; 21(11):1738-49. PubMed ID: 17002572
[TBL] [Abstract][Full Text] [Related]
13. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Ring L; Neth P; Weber C; Steffens S; Faussner A
Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
[TBL] [Abstract][Full Text] [Related]
14. LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy.
Liu CC; Prior J; Piwnica-Worms D; Bu G
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5136-41. PubMed ID: 20194742
[TBL] [Abstract][Full Text] [Related]
15. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.
Almeida M; Han L; Bellido T; Manolagas SC; Kousteni S
J Biol Chem; 2005 Dec; 280(50):41342-51. PubMed ID: 16251184
[TBL] [Abstract][Full Text] [Related]
16. Cooperative folding and ligand-binding properties of LRP6 beta-propeller domains.
Liu CC; Pearson C; Bu G
J Biol Chem; 2009 May; 284(22):15299-307. PubMed ID: 19339249
[TBL] [Abstract][Full Text] [Related]
17. LRP6 is internalized by Dkk1 to suppress its phosphorylation in the lipid raft and is recycled for reuse.
Sakane H; Yamamoto H; Kikuchi A
J Cell Sci; 2010 Feb; 123(Pt 3):360-8. PubMed ID: 20053636
[TBL] [Abstract][Full Text] [Related]
18. Secreted Frizzled-related protein-2 (sFRP2) augments canonical Wnt3a-induced signaling.
von Marschall Z; Fisher LW
Biochem Biophys Res Commun; 2010 Sep; 400(3):299-304. PubMed ID: 20723538
[TBL] [Abstract][Full Text] [Related]
19. Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells.
Fenderico N; van Scherpenzeel RC; Goldflam M; Proverbio D; Jordens I; Kralj T; Stryeck S; Bass TZ; Hermans G; Ullman C; Aastrup T; Gros P; Maurice MM
Nat Commun; 2019 Jan; 10(1):365. PubMed ID: 30664649
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors.
Holdsworth G; Slocombe P; Doyle C; Sweeney B; Veverka V; Le Riche K; Franklin RJ; Compson J; Brookings D; Turner J; Kennedy J; Garlish R; Shi J; Newnham L; McMillan D; Muzylak M; Carr MD; Henry AJ; Ceska T; Robinson MK
J Biol Chem; 2012 Aug; 287(32):26464-77. PubMed ID: 22696217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
